Retrospective Study of IBS-D Patients Previously Receiving SBI
Public ClinicalTrials.gov record NCT02661425. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Retrospective Study of Irritable Bowel Syndrome With Diarrhea (IBS-D) Patients Previously Receiving Serum-derived Bovine Serum Immunoglobulin (SBI)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a retrospective study designed to gather outcomes data from existing medical charts from patients who have taken EnteraGam for management of their IBS-D for at least eight weeks. Data from two study periods will be collected: (1) the time during which the Standard of Care (SOC) therapy (i.e., prescribed or over-the-counter as well as FDA-approved or non-approved agents) that is used immediately prior to prescribing EnteraGam; and (2) the time during which EnteraGam is used as therapy.
Study identification
- NCT ID
- NCT02661425
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 165 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2015 (Type not available)
- Primary completion
- Sep 2016 (Actual)
- Completion
- Sep 2016 (Actual)
- Last update posted
- Sep 12, 2016
2015 – 2016
United States locations
- U.S. sites
- 16
- U.S. states
- 8
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Greenwich | Connecticut | 06830 | — |
| Not listed | Hamdon | Connecticut | 06518 | — |
| Not listed | Coral Springs | Florida | 33065 | — |
| Not listed | Maitland | Florida | 32751 | — |
| Not listed | Orlando | Florida | 32836 | — |
| Not listed | Tampa | Florida | 33626 | — |
| Not listed | Winter Park | Florida | 32789 | — |
| Not listed | Smyrna | Georgia | 30080 | — |
| Not listed | Columbia | Maryland | 21045 | — |
| Not listed | St Louis | Missouri | 63141 | — |
| Not listed | Lynbrook | New York | 11563 | — |
| Not listed | New York | New York | 10065 | — |
| Not listed | Kingsport | Tennessee | 37663 | — |
| Not listed | Knoxville | Tennessee | 37923 | — |
| Not listed | Morristown | Tennessee | 37814 | — |
| Not listed | Bedford | Texas | 76022 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02661425, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 12, 2016 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02661425 live on ClinicalTrials.gov.